Tom Bäck
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Monoclonal and Polyclonal Antibodies Research
- Boron Compounds in Chemistry
- Radiation top 2%
Papers in
-
- Radiopharmaceutical Chemistry and Applications 62
- Medical Imaging Techniques and Applications 25
- Monoclonal and Polyclonal Antibodies Research 23
-
- Medical Imaging and Pathology Studies 19
- Radiation Therapy and Dosimetry 8
- Co-authors
- Sture Lindegren (53 shared papers)Holger Jensen (37 shared papers)Lars Jacobsson (34 shared papers)Stig Palm (34 shared papers)Ragnar Hultborn (24 shared papers)Per Albertsson (25 shared papers)Håkan Andersson (13 shared papers)Jörgen Elgqvist (9 shared papers)
- Journals
- Journal of Nuclear Medicine (12 papers)Cancer Biotherapy and Radiopharmaceuticals (6 papers)Blood (5 papers)International Journal of Radiation Oncology*Biology*Physics (4 papers)Nuclear Medicine and Biology (4 papers)
- Partner nations
- SwedenDenmarkUnited States
In The Last Decade
Tom Bäck
69 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 77
- Radiology, Nuclear Medicine and Imaging 1.8k
- Radiation 308
- Pulmonary and Respiratory Medicine 756
- Oncology 450
- Reproductive Medicine 58
Countries citing papers authored by Tom Bäck
This map shows the geographic impact of Tom Bäck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Bäck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Bäck more than expected).
Fields of papers citing papers by Tom Bäck
This network shows the impact of papers produced by Tom Bäck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Bäck. The network helps show where Tom Bäck may publish in the future.
Co-authors
The 25 scholars most cited alongside Tom Bäck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 223 | |
| 2 | 2001 | 134 | |
| 3 | 2010 | 103 | |
| 4 | 2020 | 69 | |
| 5 | 2008 | 66 | |
| 6 | Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35. | 2005 | 65 |
| 7 | 2007 | 62 | |
| 8 | 2019 | 60 | |
| 9 | 2010 | 58 | |
| 10 | Alpha-radioimmunotherapy of intraperitoneally growing OVCAR-3 tumors of variable dimensions: Outcome related to measured tumor size and mean absorbed dose. | 2006 | 56 |
| 11 | 2013 | 54 | |
| 12 | 2023 | 49 | |
| 13 | 2019 | 48 | |
| 14 | Radioimmunotherapy of nude mice with intraperitoneally growing ovarian cancer xenograft utilizing 211At-labelled monoclonal antibody MOv18. | 2000 | 48 |
| 15 | 2011 | 46 | |
| 16 | 2015 | 41 | |
| 17 | 211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo. | 2005 | 41 |
| 18 | 2019 | 39 | |
| 19 | Comparison of the therapeutic efficacy of 211At- and 131I-labelled monoclonal antibody MOv18 in nude mice with intraperitoneal growth of human ovarian cancer. | 2001 | 39 |
| 20 | 2017 | 38 |
About Tom Bäck
Tom Bäck is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Oncology, Pathology and Forensic Medicine and Epidemiology, having authored 71 papers that have together received 2.0k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (62 papers), Medical Imaging Techniques and Applications (25 papers), Monoclonal and Polyclonal Antibodies Research (23 papers), Medical Imaging and Pathology Studies (19 papers), Peptidase Inhibition and Analysis (9 papers), Radiation Therapy and Dosimetry (8 papers), Lymphoma Diagnosis and Treatment (6 papers) and Neuroendocrine Tumor Research Advances (6 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.8k citations), Radiation (308 citations), Pulmonary and Respiratory Medicine (756 citations), Oncology (450 citations) and Reproductive Medicine (58 citations). Tom Bäck has collaborated with scholars based in Sweden, Denmark and United States. Frequent co-authors include Sture Lindegren, Holger Jensen, Lars Jacobsson, Stig Palm, Ragnar Hultborn, Per Albertsson, Håkan Andersson, Jörgen Elgqvist, Emma Aneheim and Sofia H.L. Frost. Their work appears in journals such as Journal of Nuclear Medicine, Cancer Biotherapy and Radiopharmaceuticals, Blood, International Journal of Radiation Oncology*Biology*Physics and Nuclear Medicine and Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.